|
US5847172A
(en)
*
|
1995-06-07 |
1998-12-08 |
Magainin Pharmaceuticals Inc. |
Certain aminosterol compounds and pharmaceutical compositions including these compounds
|
|
ATE375359T1
(de)
*
|
1998-08-12 |
2007-10-15 |
Genaera Corp |
Aminosterolderivate und ihre verwendungen
|
|
EP1119361A4
(en)
*
|
1998-09-10 |
2006-10-04 |
Magainin Pharma |
TREATMENT OF CARCINOMA WITH SQUALAMINE IN COMBINATION WITH OTHER ANTI-TUMOR AGENTS
|
|
KR100704140B1
(ko)
*
|
1999-02-12 |
2007-04-09 |
더 스크립스 리서치 인스티튜트 |
혈관형성 억제제 및 항-종양 면역요법제를 포함하는, 종양 및 전이를 치료하기 위한 약제학적 조성물 및 이를 포함하는 키트
|
|
US7820718B1
(en)
|
1999-04-07 |
2010-10-26 |
Roger Williams Hospital |
Combinations of ceramide and chemotherapeutic agents for inducing cell death and uses thereof in treating cancer
|
|
ES2344831T3
(es)
|
2000-06-23 |
2010-09-08 |
Mitsubishi Tanabe Pharma Corporation |
Potenciadores de un efecto antitumoral.
|
|
US20020073441A1
(en)
|
2000-12-13 |
2002-06-13 |
Ross Brian D. |
Compositions and methods for detecting proteolytic activity
|
|
WO2003015707A2
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Method for treating lung cancers
|
|
US6793912B2
(en)
*
|
2001-08-20 |
2004-09-21 |
Transave Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
GB0126879D0
(en)
*
|
2001-11-08 |
2002-01-02 |
Astrazeneca Ab |
Combination therapy
|
|
EP1490027A4
(en)
*
|
2002-03-05 |
2010-11-10 |
Transave Inc |
METHODS OF TRAPPING BIOACTIVE AGENT IN A LIPOSOME OR LIPID COMPLEX
|
|
US9186322B2
(en)
*
|
2002-08-02 |
2015-11-17 |
Insmed Incorporated |
Platinum aggregates and process for producing the same
|
|
JP2006502233A
(ja)
*
|
2002-08-02 |
2006-01-19 |
トランセーブ，インク． |
白金凝集物およびその製造方法
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
KR101301653B1
(ko)
*
|
2002-10-29 |
2013-08-30 |
트랜세이브, 인코포레이티드 |
항감염제의 지속적인 방출
|
|
US20080194019A1
(en)
*
|
2003-09-09 |
2008-08-14 |
Beth Israel Deaconess Medical Center, Inc. |
Tumor Suppressor Lkb1 Kinase Directly Activates Amp-Activated Kinase
|
|
WO2005084710A2
(en)
*
|
2004-03-02 |
2005-09-15 |
Massachusetts Institute Of Technology |
Nanocell drug delivery system
|
|
US20070053845A1
(en)
*
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
JP2007529546A
(ja)
*
|
2004-03-18 |
2007-10-25 |
トランセイブ， インク． |
吸入によるシスプラチンの投与
|
|
EP1755623A4
(en)
*
|
2004-05-21 |
2007-10-17 |
Transave Inc |
TREATMENT OF LUNG DISEASES AND BEFORE A PULMONARY DISEASE
|
|
WO2006039569A1
(en)
*
|
2004-09-30 |
2006-04-13 |
The University Of Chicago |
Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents
|
|
EP1811963A4
(en)
*
|
2004-11-08 |
2010-01-06 |
Transave Inc |
METHOD FOR CREATING TREATMENT WITH INTRAPERITONEALLY APPLIED PLATINUM COMPOUND FORMULATIONS ON LIPID BASIS
|
|
US20070065359A1
(en)
*
|
2005-03-14 |
2007-03-22 |
Shiladitya Sengupta |
Nanocells for diagnosis and treatment of diseases and disorders
|
|
US7981876B2
(en)
|
2005-04-25 |
2011-07-19 |
Ohr Pharmaceuticals, Inc. |
Polymorphic and amorphous salt forms of squalamine dilactate
|
|
WO2006119211A2
(en)
*
|
2005-05-02 |
2006-11-09 |
Genaera Corporation |
Methods and compositions for treating ocular disorders
|
|
US20060283742A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Canel Lightning Co. Ltd. |
Multi-lamp display packaging for lamps with collapsible lampshades
|
|
US20070190182A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US20070190181A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
|
|
US20070190180A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
WO2007064658A2
(en)
*
|
2005-11-30 |
2007-06-07 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
ES2594368T3
(es)
|
2005-12-08 |
2016-12-19 |
Insmed Incorporated |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
US20100047234A1
(en)
*
|
2007-03-14 |
2010-02-25 |
Markovic Svetomir N |
Treating skin cancer
|
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9611313B2
(en)
*
|
2007-06-26 |
2017-04-04 |
University Of Miami |
Antibody-endostatin fusion protein and its variants
|
|
RU2365370C1
(ru)
*
|
2008-04-29 |
2009-08-27 |
Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН |
Способ лечения рака легкого
|
|
RU2367436C1
(ru)
*
|
2008-05-26 |
2009-09-20 |
Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН |
Способ лечения рака легкого
|
|
EP2310006A4
(en)
|
2008-07-03 |
2012-04-25 |
Mayo Foundation |
CANCER TREATMENT
|
|
RU2388503C1
(ru)
*
|
2008-08-14 |
2010-05-10 |
Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" |
Способ лечения рака легкого
|
|
RU2402280C2
(ru)
*
|
2008-12-01 |
2010-10-27 |
Федеральное государственное учреждение "Российский научно-исследовательский онкологический институт Росмедтехнологий" |
Способ прогнозирования церебральных метастазов рака легкого
|
|
RU2406452C1
(ru)
*
|
2009-06-22 |
2010-12-20 |
Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" |
Способ лечения рака легкого
|
|
RU2414894C1
(ru)
*
|
2009-06-29 |
2011-03-27 |
Учреждение Российской академии медицинских наук Российский онкологический научный центр имени Н.Н. Блохина РАМН |
Способ лечения рака легкого
|
|
US8729058B2
(en)
*
|
2009-10-27 |
2014-05-20 |
Michael Zasloff |
Methods and compositions for treating and preventing viral infections
|
|
US8623416B2
(en)
*
|
2009-11-25 |
2014-01-07 |
Michael Zasloff |
Formulations comprising aminosterols
|
|
RU2411018C1
(ru)
*
|
2009-12-22 |
2011-02-10 |
Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" |
Способ локальной химиотерапии метастазов в печень
|
|
RU2429842C1
(ru)
*
|
2010-06-15 |
2011-09-27 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ профилактики послеоперационных осложнений при комбинированном лечении больных немелкоклеточным раком легкого iii стадии
|
|
US9427477B2
(en)
|
2011-05-09 |
2016-08-30 |
Mayo Foundation For Medical Education And Research |
Cancer treatments
|
|
JP2015514708A
(ja)
*
|
2012-03-30 |
2015-05-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
抗ｅｍｐ２療法による癌幹細胞の低減
|
|
US10385395B2
(en)
|
2012-04-11 |
2019-08-20 |
The Regents Of The University Of California |
Diagnostic tools for response to 6-thiopurine therapy
|
|
ES2905368T3
(es)
|
2012-05-21 |
2022-04-08 |
Insmed Inc |
Sistemas para el tratamiento de infecciones pulmonares
|
|
CN105025904A
(zh)
|
2012-09-04 |
2015-11-04 |
埃莱森制药有限责任公司 |
用顺铂脂质复合物预防癌症的肺部复发
|
|
AU2013327638B2
(en)
|
2012-10-01 |
2018-06-14 |
Mayo Foundation For Medical Education And Research |
Cancer treatments
|
|
WO2014085526A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
US10040817B2
(en)
|
2013-10-03 |
2018-08-07 |
Enterin Laboratories, Inc. |
Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
|
|
BR112016026699B1
(pt)
|
2014-05-15 |
2022-09-13 |
Insmed Incorporated |
Uso de uma composição farmaceutica de amicacina ou de um sal farmaceuticamente aceitável desta
|
|
MX380597B
(es)
|
2014-06-13 |
2025-03-12 |
Mayo Found Medical Education & Res |
Composición con complejos de nanopartículas/anticuerpos de paclitaxel unidos a albúmina para usarse al tratar linfoma.
|
|
US10213513B2
(en)
|
2014-06-16 |
2019-02-26 |
Mayo Foundation For Medical Education And Research |
Treating myelomas
|
|
US9446148B2
(en)
|
2014-10-06 |
2016-09-20 |
Mayo Foundation For Medical Education And Research |
Carrier-antibody compositions and methods of making and using the same
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
WO2017120501A1
(en)
|
2016-01-07 |
2017-07-13 |
Mayo Foundation For Medical Education And Research |
Methods of treating cancer with interferon
|
|
US11351254B2
(en)
|
2016-02-12 |
2022-06-07 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
WO2017165440A1
(en)
|
2016-03-21 |
2017-09-28 |
Mayo Foundation For Medical Education And Research |
Methods for reducing toxicity of a chemotherapeutic drug
|
|
US11878061B2
(en)
|
2016-03-21 |
2024-01-23 |
Mayo Foundation For Medical Education And Research |
Methods for improving the therapeutic index for a chemotherapeutic drug
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
US11548946B2
(en)
|
2016-09-01 |
2023-01-10 |
Mayo Foundation For Medical Education And Research |
Carrier-PD-L1 binding agent compositions for treating cancers
|
|
EP3506950A1
(en)
|
2016-09-01 |
2019-07-10 |
Mayo Foundation for Medical Education and Research |
Methods and compositions for targeting t-cell cancers
|
|
EP3509643A1
(en)
|
2016-09-06 |
2019-07-17 |
Mayo Foundation for Medical Education and Research |
Paclitaxel-albumin-binding agent compositions and methods for using and making the same
|
|
US11590098B2
(en)
|
2016-09-06 |
2023-02-28 |
Mayo Foundation For Medical Education And Research |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
US11427637B2
(en)
|
2016-09-06 |
2022-08-30 |
Mayo Foundation For Medical Education And Research |
Methods of treating PD-L1 expressing cancer
|
|
US11083735B2
(en)
|
2017-09-08 |
2021-08-10 |
Enterin, Inc. |
Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions
|
|
US11674950B2
(en)
*
|
2017-10-31 |
2023-06-13 |
Dana-Farber Cancer Institute, Inc. |
Methods determining and treating cellular resistance to ADP-rtbosylating toxin
|
|
US11571386B2
(en)
|
2018-03-30 |
2023-02-07 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
CN116407640B
(zh)
*
|
2023-03-03 |
2025-10-31 |
河南真实生物科技有限公司 |
包含阿兹夫定和化疗试剂的抗肿瘤药物组合物
|